Novartis Expert Denies Zometa Caused Bone Death In NJ Trial
Novartis Pharmaceuticals Corp. couldn't win a midtrial judgment Thursday in a New Jersey lawsuit in multicounty litigation over its bone drug Zometa, but did begin calling witnesses to combat claims that...To view the full article, register now.
Already a subscriber? Click here to view full article